Marshall Wace North America L.P. - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 103 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q3 2021$223,000
-88.2%
5,819
-91.3%
0.00%
-87.5%
Q2 2021$1,885,000
-35.9%
66,761
-24.9%
0.01%
-33.3%
Q1 2021$2,940,000
-17.3%
88,947
-9.5%
0.01%
-25.0%
Q4 2020$3,553,000
+10.8%
98,276
+3.9%
0.02%
-23.8%
Q3 2020$3,206,00094,5800.02%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$394,762,58198.29%
venBio Partners LLC 1,035,396$36,435,58513.19%
Nan Fung Group Holdings Ltd 368,665$12,973,3218.29%
Vivo Capital, LLC 2,606,247$91,713,8326.33%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 570,500$20,070,1906.11%
Altium Capital Management LP 149,889$5,274,5943.99%
AlphaCentric Advisors LLC 118,000$4,152,4202.30%
ASHFORD CAPITAL MANAGEMENT INC 449,038$15,801,6472.21%
NEUMEIER POMA INVESTMENT COUNSEL LLC 636,240$22,389,2862.05%
TANG CAPITAL MANAGEMENT LLC 271,200$9,543,5281.40%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders